Brexafemme
Chemical Name | ibrexafungerp |
Dosage Form | Tablet (oral; 150 mg) |
Drug Class | Triterpenoid antifungals |
System | Multiple |
Company | SCYNEXIS |
Approval Year | 2021 |
Indication
- For the treatment of adult and post-menarchal pediatric females with vulvovaginal candidiasis (VVC).